The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Virginia’s PDMP.
This resource provides a space for patients to record information about the medications they take including the dose, how often they take the medication, the reason for the medication, and the prescriber’s name. This information can be shared with health care providers and can be used to prevent patients taking
This one page document lists names for prescription opioid pain medications including generic names, brand names, and street or slang names.
A one page document for patients and caregivers with information about the risks of prescription medications for children and guidance for how to safely store medications in the home.
The Arizona Department of Health Services prepared a 2017 review of opioid related policies in all 50 states to assist decision makers in evaluating what additional programmatic and policy actions they might want to adopt. This appendix to the report lists state opioid prescribing regulations and guidelines.
The Arizona Department of Health Services created this frequently asked questions resource to explain the state’s opioid prescribing and opioid treatment rules.
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page document lists the steps prescribers need to take to implement electronic prescribing in their practices.
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This 2 page document answers frequently asked questions about the electronic prescribing program.
Arizona adopted a law requiring all Arizona health care providers to use electronic prescribing for all Schedule II controlled substances by January 1, 2020. This one page document summarizes costs associated with adopting electronic prescribing of controlled substances in the most widely
This 2018 report is a comprehensive guide on how to design, implement, and manage a state Prescription Drug Monitoring Program (PDMP). Produced by the PDMP Training and Technical Assistance Center at Brandeis University, the guide includes a history of PDMPs, a review of state